Technologies: Preclinical imaging for drug development

Drug Discovery Today: Technologies

Volumn 10, Issue 3, 2013, Pages

  Matthews, Paul M ^a,b   Coatney, Robert ^c   Alsaid, Hasan ^c   Jucker, Beat ^c   Ashworth, Sharon ^a   Parker, Christine ^a   Changani, Kumar ^d  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c GLAXOSMITHKLINE   (United States)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3' FLUOROTHYMIDINE F 18; 6 FLUORODOPA F 18; ACETIC ACID C 11; ADENOSINE TRIPHOSPHATE; AMMONIA N 13; CREATINE PHOSPHATE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; FLUOROMIZONIDAZOLE F 18; FLUOROTYROSINE F 18; GADOLINIUM; METHIONINE C 11; PENTETATE TECHNETIUM TC 99M; RUBIDIUM 82; THYMIDINE C 11; TRACER; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; WATER O 15;

B SCAN; BIOENERGY; BIOMICROSCOPY; CARBON NUCLEAR MAGNETIC RESONANCE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOGRAPHY; DRUG DEVELOPMENT; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TARGETING; ECHOGRAPHY; HEART FAILURE; HIGH ENERGY PHOSPHATE; HUMAN; IN VIVO STUDY; LUNG EDEMA; M MODE ECHOCARDIOGRAPHY; MOLECULAR IMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POSITRON EMISSION TOMOGRAPHY; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TECHNOLOGY; THREE DIMENSIONAL IMAGING; TOXICITY TESTING; TRANSLATIONAL RESEARCH; X RAY COMPUTERIZED TOMOGRAPHY;

ANIMALS; DIAGNOSTIC IMAGING; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY; HUMANS; PHARMACOKINETICS;

EID: 84879218713     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2012.04.004     Document Type: Review

References (49)

1. M. Rudin Imaging in Drug Discovery and Early Clinical Trials (Progress in Drug Research) 2005 Birkhauser
2. P.M. Matthews Non-invasive imaging in experimental medicine for drug development Curr Opin Pharmacol 11 2011 501 507
3. C.E. Elwell, and C.E. Cooper Making light work: illuminating the future of biomedical optics Philos Trans A Math Phys Eng Sci 369 2011 4358 4379
4. K. Shah, and R. Weissleder Molecular optical imaging: applications leading to the development of present day therapeutics NeuroRx 2 2005 215 225
5. M.F. Lythgoe Neuroimaging of animal models of brain disease Br Med Bull 65 2003 235 257
6. N.A. Bock In vivo magnetic resonance imaging and semiautomated image analysis extend the brain phenotype for cdf/cdf mice J Neurosci 26 2006 4455 4459
7. K.K. Changani A longitudinal magnetic resonance imaging (MRI) study of differences in abdominal fat distribution between normal mice, and lean overexpressers of mitochondrial uncoupling protein-3 (UCP-3) Diabetes Obes Metab 5 2003 99 105
8. F. Wiesmann Dobutamine-stress magnetic resonance microimaging in mice: acute changes of cardiac geometry and function in normal and failing murine hearts Circ Res 88 2001 563 569
9. K. Montet-Abou The role of imaging and molecular imaging in the early detection of metabolic and cardiovascular dysfunctions Int J Obes (Lond) 34 Suppl 2 2010 S67 S81
10. M. Rudin Molecular imaging in drug discovery and development: potential and limitations of nonnuclear methods Mol Imaging Biol 7 2005 5 13
11. A. Borthakur Sensitivity of MRI to proteoglycan depletion in cartilage: comparison of sodium and proton MRI Osteoarthritis Cartilage 8 2000 288 293
12. N.R. Sibson MRI detection of early endothelial activation in brain inflammation Magn Reson Med 51 2004 248 252
13. A.C. Lindsay, and R.P. Choudhury Form to function: current and future roles for atherosclerosis imaging in drug development Nat Rev Drug Discov 7 2008 517 529
14. J.W. Bulte In vivo magnetic resonance tracking of magnetically labeled cells after transplantation J Cereb Blood Flow Metab 22 2002 899 907
15. Y. Fu, and D.L. Kraitchman Stem cell labeling for noninvasive delivery and tracking in cardiovascular regenerative therapy Expert Rev Cardiovasc Ther 8 2010 1149 1160
16. P.M. Matthews, and P. Jezzard Functional magnetic resonance imaging J Neurol Neurosurg Psychiatry 75 2004 6 12
17. P.M. Matthews Applications of fMRI in translational medicine and clinical practice Nat Rev Neurosci 7 2006 732 744
18. A.J. Schwarz Pharmacological modulation of functional connectivity: the correlation structure underlying the phMRI response to d-amphetamine modified by selective dopamine D3 receptor antagonist SB277011A Magn Reson Imaging 25 2007 811 820
19. A.J. Schwarz Concurrent pharmacological MRI and in situ microdialysis of cocaine reveal a complex relationship between the central hemodynamic response and local dopamine concentration Neuroimage 23 2004 296 304
20. A.J. Schwarz Functional connectivity in the pharmacologically activated brain: resolving networks of correlated responses to d-amphetamine Magn Reson Med 57 2007 704 713
21. F. Schick Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue Magn Reson Med 29 1993 158 167
22. G.W. Cline In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism J Biol Chem 276 2001 20240 20244
23. A. Viale Hyperpolarized agents for advanced MRI investigations Q J Nucl Med Mol Imaging 53 2009 604 617
24. S. Neubauer The failing heart - an engine out of fuel N Engl J Med 356 2007 1140 1151
25. 31P NMR magnetization-transfer measurements of ATP turnover during steady-state isometric muscle contraction in the rat hind limb in vivo Biochemistry 28 1989 4887 4893
26. 31P NMR Proc Natl Acad Sci U S A 97 2000 6880 6884
27. C.T. Badea In vivo small-animal imaging using micro-CT and digital subtraction angiography Phys Med Biol 53 2008 R319 R350
28. S. Shofer A micro-CT analysis of murine lung recruitment in bleomycin-induced lung injury J Appl Physiol 105 2008 669 677
29. F.S. Foster Ultrasound biomicroscope for mouse imaging Ultrasound Med Biol 26 Suppl 2 2000
30. M.A. Pysz Assessment and monitoring tumor vascularity with contrast-enhanced ultrasound maximum intensity persistence imaging Invest Radiol 46 2011 187 195
31. B.A. Kaufmann, and J.R. Lindner Molecular imaging with targeted contrast ultrasound Curr Opin Biotechnol 18 2007 11 16
32. B.J. Pichler PET/MRI: paving the way for the next generation of clinical multimodality imaging applications J Nucl Med 51 2010 333 336
33. V.J. Cunningham A method of studying pharmacokinetics in man at picomolar drug concentrations Br J Clin Pharmacol 32 1991 167 172
34. G.B. Fox Translational neuroimaging of the CNS: novel pathways to drug development Mol Interv 9 2009 302 313
35. P.H. Elsinga Positron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain Mol Imaging Biol 7 2005 37 44
36. 11C]S(+)- rolipram in vitro and in vivo, and their use as PET radiotracers for the quantificative assay of PDE4 Synapse 55 2005 270 279
37. S. Momosaki Rat-PET study without anesthesia: anesthetics modify the dopamine D1 receptor binding in rat brain Synapse 54 2004 207 213
38. 11C]DASB in conscious common marmosets: comparison with rhesus monkeys Synapse 64 2010 594 601
39. 18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec) Eur J Cancer 39 2003 2012 2020
40. H. Prenen Establishment of a mouse gastrointestinal stromal tumour model and evaluation of response to imatinib by small animal positron emission tomography Anticancer Res 26 2A 2006 1247 1252
41. 18F] fluorothymidine into L5178Y tumours in vivo is dependent on thymidine kinase 1 protein levels Eur J Nucl Med Mol Imaging 32 2005 257 263
42. 18F]fluorothymidine as a new marker for monitoring tumor response to antiproliferative therapy in vivo with positron emission tomography Cancer Res 63 2003 3791 3798
43. 18F]fluorotyrosine in tumor bearing mice Nucl Med Biol 20 1993 895 899
44. Y. Wu A noninvasive [(99m)Tc]DTPA SPECT/CT imaging methodology as a measure of lung permeability in a guinea pig model of COPD Mol Imaging Biol 2010
45. Y.H. Kim Plasticity of the attentional network after brain injury and cognitive rehabilitation Neurorehabil Neural Repair 23 2009 468 477
46. 177Lu-labeled Tyr3-octreotate radionuclide therapy J Nucl Med 51 2010 1962 1968
47. S. Singhal Nanotechnology applications in surgical oncology Annu Rev Med 61 2010 359 373
48. J. Walther Optical coherence tomography in biomedical research Anal Bioanal Chem 400 2011 2721 2743
49. S. Kitson Clinical applications of positron emission tomography (PET) imaging in medicine, oncology, brain diseases and cardiology Curr Radiopharm 2 2009 224 253